Hyperchloremic Metabolic Acidosis due to Cholestyramine: A Case Report and Literature Review

Joint Authors

McQuillan, Rory
Kamar, Fareed B.

Source

Case Reports in Nephrology

Issue

Vol. 2015, Issue 2015 (31 Dec. 2015), pp.1-3, 3 p.

Publisher

Hindawi Publishing Corporation

Publication Date

2015-09-03

Country of Publication

Egypt

No. of Pages

3

Main Subjects

Diseases

Abstract EN

Cholestyramine is a bile acid sequestrant that has been used in the treatment of hypercholesterolemia, pruritus due to elevated bile acid levels, and diarrhea due to bile acid malabsorption.

This medication can rarely cause hyperchloremic nonanion gap metabolic acidosis, a complication featured in this report of an adult male with concomitant acute kidney injury.

This case emphasizes the caution that must be taken in prescribing cholestyramine to patients who may also be volume depleted, in renal failure, or taking spironolactone.

American Psychological Association (APA)

Kamar, Fareed B.& McQuillan, Rory. 2015. Hyperchloremic Metabolic Acidosis due to Cholestyramine: A Case Report and Literature Review. Case Reports in Nephrology،Vol. 2015, no. 2015, pp.1-3.
https://search.emarefa.net/detail/BIM-1058957

Modern Language Association (MLA)

Kamar, Fareed B.& McQuillan, Rory. Hyperchloremic Metabolic Acidosis due to Cholestyramine: A Case Report and Literature Review. Case Reports in Nephrology No. 2015 (2015), pp.1-3.
https://search.emarefa.net/detail/BIM-1058957

American Medical Association (AMA)

Kamar, Fareed B.& McQuillan, Rory. Hyperchloremic Metabolic Acidosis due to Cholestyramine: A Case Report and Literature Review. Case Reports in Nephrology. 2015. Vol. 2015, no. 2015, pp.1-3.
https://search.emarefa.net/detail/BIM-1058957

Data Type

Journal Articles

Language

English

Notes

Includes bibliographical references

Record ID

BIM-1058957